Ellevest’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Ellevest's ALNY Position: Q3 2026 in Review
Ellevest increased its Alnylam Pharmaceuticals (ALNY) stake by 24% in Q3 2026, buying an estimated $115K and bringing the position to 2,293 shares worth $565K. The position accounts for 0.07% of the portfolio, ranked #218.
Ellevest first reported a position in ALNY in Q2 2020 and has held it in 24 quarters since. The position peaked at $608K in Q1 2026. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Ellevest held 2,293 shares of Alnylam Pharmaceuticals worth $565K as of Q3 2026.
- Ellevest bought 451 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $115K.
- Alnylam Pharmaceuticals made up 0.07% of Ellevest's portfolio in Q3 2026, its #218 holding.
- Ellevest first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
- Ellevest's Alnylam Pharmaceuticals position peaked at $608K in Q1 2026.
- 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.